Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-4,249
Closed -$651K – 739
2024
Q1
$651K Buy
+4,249
New +$634K 0.02% 408
2022
Q1
– Sell
-1,301
Closed -$227K – 739
2021
Q4
$227K Sell
1,301
-378
-23% -$63K 0.01% 642
2021
Q3
$278K Buy
1,679
+26
+2% +$4.48K 0.01% 556
2021
Q2
$297K Sell
1,653
-57
-3% -$10.4K 0.01% 539
2021
Q1
$330K Sell
1,710
-64
-4% -$12.3K 0.01% 484
2020
Q4
$358K Sell
1,774
-481
-21% -$99.5K 0.02% 401
2020
Q3
$474K Sell
2,255
-631
-22% -$141K 0.02% 293
2020
Q2
$633K Sell
2,886
-50
-2% -$9.99K 0.04% 240
2020
Q1
$509K Sell
2,936
-395
-12% -$65.3K 0.04% 225
2019
Q4
$511K Sell
3,331
-150
-4% -$22.4K 0.03% 275
2019
Q3
$529K Buy
3,481
+150
+5% +$23.7K 0.03% 260
2019
Q2
$510K Buy
3,331
+430
+15% +$65.7K 0.03% 281
2019
Q1
$465K Hold
2,901
– – 0.03% 316
2018
Q4
$447K Buy
+2,901
New +$452K 0.03% 325

Other funds holding CLX

Bailard's CLX Position: Q2 2024 in Review

Bailard sold out of Clorox (CLX) in Q2 2024, closing a stake of 4,249 shares — an estimated $651K sold.

Bailard first reported a position in CLX in Q4 2018 and held it in 14 quarters. The position peaked at $651K in Q1 2024. 1,093 funds tracked by Wall St. Rank hold CLX as of Q2 2024.

  • Bailard reported no remaining Clorox position as of Q2 2024 after selling out during the quarter.
  • Bailard sold 4,249 Clorox shares in Q2 2024, an estimated $651K.
  • Bailard first reported a position in Clorox in Q4 2018 and held it in 14 quarters.
  • Bailard's Clorox position peaked at $651K in Q1 2024.
  • 1,093 funds tracked by Wall St. Rank held Clorox as of Q2 2024.

Based on Bailard's 13F filing for Q2 2024, filed 25 Jul 2024.